Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
Author | Vogt, Anne-Cathrine |
Author | Augusto, Gilles |
Author | Martina, Byron |
Author | Chang, Xinyue |
Author | Nasrallah, Gheyath |
Author | Speiser, Daniel |
Author | Vogel, Monique |
Author | Bachmann, Martin |
Author | Mohsen, Mona |
Available date | 2022-05-23T05:36:59Z |
Publication Date | 2022-05 |
Publication Name | Vaccines |
Identifier | http://dx.doi.org/10.3390/vaccines10050743 |
Citation | Vogt, A.-C.S.; Augusto, G.; Martina, B.; Chang, X.; Nasrallah, G.; Speiser, D.E.; Vogel, M.; Bachmann, M.F.; Mohsen, M.O. Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron. Vaccines 2022, 10, 743. https://doi.org/10.3390/vaccines10050743 |
Abstract | In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1.529) escapes neutralizing antibody responses, by physio-chemical characterization of this variant in comparison to the wild-type Wuhan and the Delta variant (B.1.617.2). Convalescent sera, as well as sera obtained from participants who received two or three doses of mRNA vaccines (Moderna-mRNA-1273® or Pfizer-BNT162b2®), were used for comparison in this study. Our data demonstrate that both Delta, as well as Omicron variants, exhibit a higher affinity for the receptor ACE2, facilitating infection and causing antibody escape by receptor affinity (affinity escape), due to the reduced ability of antibodies to compete with RBD-receptor interaction and virus neutralization. In contrast, only Omicron but not the Delta variant escaped antibody recognition, most likely because only Omicron exhibits the mutation at E484A, a position associated with reduced recognition, resulting in further reduced neutralization (specificity escape). Nevertheless, the immunizations with RNA-based vaccines resulted in marked viral neutralization in vitro for all strains, compatible with the fact that Omicron is still largely susceptible to vaccination-induced antibodies, despite affinity- and specificity escape. |
Sponsor | This research was funded by Saiba, A.G., the Swiss National Science Foundation (SNF grants 31003_185114 and IZRPZO_194968). |
Language | en |
Publisher | MDPI |
Subject | Omicron Delta SARS-CoV-2 antibody |
Type | Article |
Issue Number | 5 |
Volume Number | 10 |
ESSN | 2076-393X |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Sciences [738 items ]
-
COVID-19 Research [835 items ]